Heat therapy with chemotherapy and radiation for pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism, Injuries & trauma clinical trials.
This study is testing a new combination treatment that adds heat therapy to standard chemotherapy and radiation. The goal is to see if this approach can help shrink or control pancreatic tumors that haven't spread to other organs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 80 years old
- Have been diagnosed with locally advanced or borderline pancreatic cancer (confirmed by biopsy)
- Be in generally good health (can manage light activity and self-care)
- Have adequate liver, kidney, and blood cell function (blood tests will confirm)
- Not have cancer that has spread to distant organs
- If you are a woman who can have children, you must agree to use effective contraception during and for 6 months after the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial combines two treatments for advanced pancreatic cancer that hasn't spread: a special endoscopic procedure that uses heat to destroy cancer cells (radiofrequency ablation) and a standard chemotherapy drug combination (FOLFIRINOX). The goal is to see if this combination is safe and can help control the tumor better than chemotherapy alone.
This trial studies whether giving chemotherapy before surgery, and possibly adding a focused high-dose radiation treatment, can improve outcomes for people with borderline resectable pancreatic cancer. It aims to shrink or control the cancer and help more patients get to surgery safely.
This trial tests whether giving radiation therapy before a combination of two chemotherapy drugs (NALIRIFOX) is better than chemotherapy alone for people with pancreatic cancer that is on the edge of being removable. The goal is to see if adding radiation helps shrink the tumor enough to make surgery possible and improve outcomes.
This trial tests a combination of standard chemotherapy, MRI-guided radiation, and surgery for people with locally advanced pancreatic cancer that might be removable. The goal is to see if this approach can make more tumors resectable.
This trial tests a treatment that combines heating chemotherapy drugs and delivering them directly into the abdomen (HIPEC) with standard chemotherapy through a vein. It is for people whose pancreatic cancer has spread to the lining of the abdomen but not to other organs, and who have not had prior cancer treatment.
This trial tests adding whole-body heat treatment to standard chemotherapy for people with advanced pancreatic cancer that has spread. The heat might make the chemotherapy work better.
Hear when a new Borderline and Locally Advanced Pancreatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.